Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
Son Tran, Tony H. Truong, Aru Narendran
European Journal of Cancer (2021) Vol. 159, pp. 259-274
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021
Weiqiu Jin, Kaichen Huang, Zeyu Ding, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Higher Prevalence of Long COVID Observed in Cancer Survivors: Insights from a US Nationwide Survey
Lingchen Wang, Wei Yang
Annals of Epidemiology (2025)
Closed Access | Times Cited: 2
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
Jérôme Barrière, Michel Carlès, Clarisse Audigier-Valette, et al.
European Journal of Cancer (2021) Vol. 162, pp. 182-193
Open Access | Times Cited: 52
Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis
Cong Liu, Junghwan Lee, Casey Ta, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 5, pp. e35311-e35311
Open Access | Times Cited: 27
Third dose of COVID‐19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titres
Ondrej Šušol, Barbora Hájková, Hana Zelená, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 3, pp. 302-305
Closed Access | Times Cited: 24
Cancer Patients during COVID-19 Pandemic: A Mini-Review
Maryam Linjawi, Hira Shakoor, Serene Hilary, et al.
Healthcare (2023) Vol. 11, Iss. 2, pp. 248-248
Open Access | Times Cited: 14
Serum Neutralizing Antibody Titers 12 Months After Coronavirus Disease 2019 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US Population
Min Zhao, Rebecca Slotkin, Amar H. Sheth, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e391-e399
Open Access | Times Cited: 20
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
Pierre-Étienne Heudel, Bertrand Favier, Marie-Laure Solodky, et al.
European Journal of Cancer (2022) Vol. 165, pp. 174-183
Open Access | Times Cited: 19
Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
Helen Kakkassery, Esme Carpenter, Piers Patten, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 12, pp. 1082-1099
Open Access | Times Cited: 19
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
Erika Zecca, Manuela Rizzi, Stelvio Tonello, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1766-1766
Open Access | Times Cited: 17
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey
Yurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
Danielle Gilbert, Junxiao Hu, Theresa Medina, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 9
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study
Yunus Kuijpers, H. Susan J. Picavet, Lia de Rond, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA
Andhika Rachman, Anggraini Iriani, Lugyanti Sukrisman, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281907-e0281907
Open Access | Times Cited: 6
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
Ioannis Trontzas, Ioannis Vathiotis, Christina Economidou, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 618-618
Open Access | Times Cited: 10
Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges
Muna Almasri, Khalifa Bshesh, Wafa Khan, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5630-5630
Open Access | Times Cited: 9
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
Diogo Martins-Branco, Guilherme Nader Marta, Ana Tečić Vuger, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3075-3080
Open Access | Times Cited: 9
SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy
David K. Lau, Maria Aresu, Tim Planche, et al.
The Oncologist (2022) Vol. 28, Iss. 1, pp. e1-e8
Open Access | Times Cited: 8
COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, China
Leiwen Fu, Shuang Wu, Bingyi Wang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study
Kei Nakashima, Masayuki Ishida, Hiroki Matsui, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose
Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2687-2694
Open Access | Times Cited: 1
Clinical characteristics and prognostic factors of COVID-19 infection among cancer patients during the December 2022 – February 2023 Omicron variant outbreak
Lili Liu, Yu-Wei Liao, Xiaohua Yu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Humoral Response to SARS-CoV-2 Vaccine-Boost in Cancer Patients: A Case Series from a Southern European Cancer Center
Júlio Oliveira, Pedro Cruz, Tânia R. Dias, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1207-1207
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top